These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 22469921

  • 1. Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells.
    Li J, Liang S, Jin H, Xu C, Ma D, Lu X.
    Oncol Rep; 2012 Jun; 27(6):1835-42. PubMed ID: 22469921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H.
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
    Li B, Song Y, Liu TJ, Cui YB, Jiang Y, Xie ZS, Xie SL.
    Oncol Rep; 2013 May; 29(5):1932-8. PubMed ID: 23440286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T, Nohata N, Watanabe-Takano H, Yoshino H, Hidaka H, Fujimura L, Fuse M, Yamasaki T, Enokida H, Nakagawa M, Hanazawa T, Okamoto Y, Seki N.
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.
    Oncogene; 2012 Feb 09; 31(6):764-75. PubMed ID: 21725366
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ, Guo RD, Guo RM, Sheng W, Yin LR.
    J Cell Biochem; 2013 Jul 09; 114(7):1464-73. PubMed ID: 23296900
    [Abstract] [Full Text] [Related]

  • 19. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z.
    Gynecol Oncol; 2010 Oct 09; 119(1):125-30. PubMed ID: 20624637
    [Abstract] [Full Text] [Related]

  • 20. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
    Sun G, Zhou J, Yin A, Ding Y, Zhong M.
    Int J Oncol; 2008 May 09; 32(5):1065-71. PubMed ID: 18425333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.